COVID-19: Ivermectin “antiparasitic drug” as therapeutic drug: Nobel Prize developed by Mr. Omura
COVID-19:
Kitasato University: Professor Emeritus Satoshi Omura
Nobel Prize-winning Professor Emeritus Satoshi Omura developed Ivermectin.
Nowadays, “antiparasitic drugs” are expected as candidates for new coronavirus therapeutic agents.
“Ivermectin”:
It is a remedy for infectious diseases caused by parasites in the body and is effective mainly in Africa.
Research teams in the United States and Australia have reported that the new coronavirus is also effective.
Satoshi Omura Memorial Institute: Hideaki Hanaki Director
Kitazato University in Japan also started “Ivermectin” research in March.
We believe that ivermectin has the effect of suppressing the growth of the virus.
We would like to administer this drug to patients and obtain approval within one year.
Ivermectin has been administered to more than 500 million people worldwide, and it is highly safe.
KHB East Japan Broadcasting
http://www.khb-tv.co.jp/news2/annNews/000183113.html
Nobel Prize / Prof. Satoshi Omura / Parasitic drugs work on new coronas! One-third fatality rate for severely ill
Showa University School of Medicine:
“we would like to see the patient’s background a little more, but we can clearly expect it,” explains Yoshito Nimura, a specially appointed professor.
Nobel Prize / Satoshi Omura:
Ivermectin is a promising therapeutic drug.
“It was good as a result of actually using ivermectin clinically.” After all it must have worked.
Kitasato University:
From March 2020, as an observational study, administration to infected persons has started.
The drug has been administered to more than 500 million people so far, but no serious side effects have been reported.
J-CAST TV Watch